ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1187

$457K Total Retail Price of All Prescriptions

Rank: 77 out of 1187

632 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oregon
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

19% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 661 553 113 S3 1 5
SIMVASTATIN 462 439 89 2 3
OMEPRAZOLE 431 399 98 3 4
LEVOTHYROXINE SODIUM 427 403 91 4 2
LISINOPRIL 385 340 90 5 1
METFORMIN HCL 337 323 61 6 7
ATORVASTATIN CALCIUM 289 269 53 7 8
LOVASTATIN 262 247 51 8 16
METOPROLOL TARTRATE 248 243* 55 9 15
AMLODIPINE BESYLATE 232 227* 51 10 6
WARFARIN SODIUM 208 192 54 11 13
FUROSEMIDE 196 173 48 12 9
SERTRALINE HCL 195 173 37 13 23
METOPROLOL SUCCINATE 181 176* 48 14 18
GLIMEPIRIDE 169 152 37 15 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 160* 39 16 27
POTASSIUM CHLORIDE 161 129 33 17 17
HYDROCHLOROTHIAZIDE 153 148* 35 18 10
ALPRAZOLAM 149 144* 27 B 19 35
ATENOLOL 149 138 32 19 11
CITALOPRAM HBR 146 123 28 21 20
LORAZEPAM 137 108 27 B 22 32
ZOLPIDEM TARTRATE 131 97 26 23 24
TAMSULOSIN HCL 119 114* 27 24 25
LOSARTAN POTASSIUM 110 105* 28 25 14
PROAIR HFA 94 89* 27 26 29
FLUTICASONE PROPIONATE 90 72 32 27 34
PRAVASTATIN SODIUM 89 84* 17 28 19
GABAPENTIN 88 88 17 29 12
SYNTHROID 84 <11 <11 30 91
CARVEDILOL 80 75* 26 31 26
FLUOXETINE HCL 79 54 14 32 33
CLOPIDOGREL 79 79 14 32 36
MELOXICAM 77 50 25 34 53
PREMARIN 74 69* 15 R 35 125
ALENDRONATE SODIUM 74 74 12 35 28
TRAZODONE HCL 71 56 18 37 21
PANTOPRAZOLE SODIUM 70 65* 27 38 41
TRIAMTERENE-HYDROCHLOROTHIAZID 70 70 22 38 101
OXYBUTYNIN CHLORIDE ER 69 57 11 40 115
AZITHROMYCIN 66 61* 60 41 65
PREDNISONE 66 61* 38 41 42
DONEPEZIL HCL 63 63 12 43 43
LOSARTAN-HYDROCHLOROTHIAZIDE 61 61 14 44 57
TRAMADOL HCL 58 53* 17 45 30
PAROXETINE HCL 58 <11 <11 45 52
POLYETHYLENE GLYCOL 3350 57 52* 21 47 60
LANTUS 56 51* 14 48 48
HYDROCORTISONE 54 49* 22 49 203
SPIRONOLACTONE 53 48* 12 50 58
ALLOPURINOL 52 47* 16 51 30
AMITRIPTYLINE HCL 52 <11 <11 R 51 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 45* 30 53 105
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.